Overview

Dimethyldiguanide Combined With Aromatase Inhibitor (AI) in Metastatic Breast Cancer

Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
The addition of dimethyldiguanide might increase the efficacy of AI treatment in metastatic breast cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Xichun Hu
Treatments:
Aromatase Inhibitors
Exemestane
Letrozole